Exane Derivatives Perkinelmer Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Perkinelmer Inc stock. As of the latest transaction made, Exane Derivatives holds 23 shares of PKI stock, worth $2,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 745
96.91%
Holding current value
$2,783
Previous $129,000
97.67%
% of portfolio
0.0%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding PKI
# of Institutions
535Shares Held
112MCall Options Held
179KPut Options Held
66.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18MShares$2.18 Billion1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$1.7 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY8.78MShares$1.06 Billion0.02% of portfolio
-
Select Equity Group, L.P. New York, NY7.37MShares$892 Million3.66% of portfolio
-
Janus Henderson Group PLC London, X06.23MShares$753 Million0.41% of portfolio
About PERKINELMER INC
- Ticker PKI
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 126,224,000
- Market Cap $15.3B
- Description
- PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...